2-Chloro-N6-cyclopentyladenosine

CAS No. 37739-05-2

2-Chloro-N6-cyclopentyladenosine ( CCPA; 2-Chloro-N6-cyclopentyladenosine; 2-CHLORO-N-CYCLOPENTYLADENOSINE; 2-chloro-N(6)cyclopentyladenosine )

Catalog No. M24336 CAS No. 37739-05-2

2-Chloro-N6-cyclopentyladenosine is a potent and selective agonist of adenosine A1 receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 180 In Stock
10MG 257 In Stock
25MG 434 In Stock
50MG 620 In Stock
100MG 883 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-Chloro-N6-cyclopentyladenosine
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Chloro-N6-cyclopentyladenosine is a potent and selective agonist of adenosine A1 receptor.
  • Description
    2-Chloro-N6-cyclopentyladenosine is a potent and selective agonist of adenosine A1 receptor.
  • Synonyms
    CCPA; 2-Chloro-N6-cyclopentyladenosine; 2-CHLORO-N-CYCLOPENTYLADENOSINE; 2-chloro-N(6)cyclopentyladenosine
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    Adenosine A1?receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    37739-05-2
  • Formula Weight
    369.8
  • Molecular Formula
    C15H20ClN5O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC[C@H]([C@H]([C@H]1O)O)O[C@H]1n1c2nc(Cl)nc(NC3CCCC3)c2nc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang X , Xia J , Qian D , et al. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.[J]. Cardiology, 2014, 129(3):153-62.
molnova catalog
related products
  • SKF38393 HCl

    SKF38393 HCl is a selective dopamine D1/D5 receptor agonist.

  • Zeaxanthin

    Lutein and Zeaxanthin in neural tissue may have biological effects that include antioxidation, anti-inflammation, and structural actions.

  • Catharanthine

    Catharanthine inhibits nicotinic receptor mediated diaphragm contractions with IC50 of 59.6 μM.